Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher    DHR

DANAHER (DHR)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

X-Rite Agrees To Be Acquired By Danaher In $478 Million Deal

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/10/2012 | 02:45pm CEST

Color-measurement technology company X-Rite Inc. (XRIT) agreed to be acquired by diversified manufacturer Danaher Corp. (>> Danaher Corporation) in a deal valued at $478 million.

The $5.55-a-share offer represents a 39% premium to Monday's closing price. X-Rite shares closed Monday at $4 each and were halted in recent premarket trading. The stock is down 14% this year.

X-Rite Chief Executive Thomas J. Vacchiano Jr. said that joining Danaher will give the company--known for Pantone color matching system--resources to achieve its growth goals, expanded access to new market and complementary technologies.

After the deal closes, anticipated in the current quarter, X-Rite will operate as a standalone unit in Danaher's product identification group and existing management will remain in senior leadership positions.

Danaher expects the acquisition will complement its Esko digital packaging design capabilities and further its leading position in the product identification industry. The diversified toolmaker has been relying on acquisitions to bolster a slow-growing revenue base.

Including debt assumption and net of cash, the deal is valued at a total of $625 million.

Danaher shares closed Monday at $54.59 and were inactive in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; [email protected]

Stocks mentioned in the article : Danaher Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER
06/21 DANAHER CORP /DE/ : Other Events, Financial Statements and Exhibits (form 8-K)
06/21 DANAHER : Schedules Second Quarter 2017 Earnings Conference Call
06/20 DANAHER : Announces Pricing Of Euro-Denominated Senior Notes Offering
06/19 DANAHER CORP /DE/ : Other Events, Financial Statements and Exhibits (form 8-K)
06/13 DANAHER : To present at goldman sachs global healthcare conference
06/08 DANAHER : to Present at Goldman Sachs Global Healthcare Conference
05/25 DANAHER : To Present At Bernstein Strategic Decisions Conference
05/17 Toothwash Equipment Market 2017 - a-Dec, 3M Company, Biolase, Planmeca Oy, Da..
05/15 DANAHER : To Present At Electrical Products Group Conference
05/11 DANAHER CORPORATION (NYSE : DHR) Files An 8-K Departure of Directors or Certain ..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
11:53a Philips to buy medical device maker Spectranetics for 1.9 billion euros
08:24aDJROYAL PHILIPS : to Buy Spectranetics for $2.15 Billion
06/22DJROYAL PHILIPS : Philips to Buy Electrical Geodesics for GBP29 Million
06/19 PERKINELMER : to buy Germany's Euroimmun for about $1.3 billion
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
06/20 Danaher prices Euro debt offering
06/12 One Year Later Post Spin-Off For Danaher Corporation
06/07 Danaher downgraded to Neutral from Buy at Janney
06/05 Danaher Corporation (DHR) Presents At Bernstein's 33rd Annual Strategic Decis..
05/30 Tracking Charles Akre's Akre Capital Management Portfolio - Q1 2017 Update
Advertisement
Financials ($)
Sales 2017 17 963 M
EBIT 2017 3 320 M
Net income 2017 2 280 M
Debt 2017 8 835 M
Yield 2017 0,65%
P/E ratio 2017 24,86
P/E ratio 2018 22,51
EV / Sales 2017 3,83x
EV / Sales 2018 3,49x
Capitalization 59 950 M
More Financials
Chart DANAHER
Duration : Period :
Danaher Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Full-screen chart
Technical analysis trends DANAHER
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 92,3 $
Spread / Average Target 9,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER8.71%59 950
THERMO FISHER SCIENTIF..23.10%67 955
BOSTON SCIENTIFIC CORP..28.57%38 083
ROYAL PHILIPS12.21%34 752
INTUITIVE SURGICAL47.60%34 483
ILLUMINA37.74%25 801
More Results